跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nadiquin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nadiquin
Approved
STANDARD
Nadiquin
Wockhardt Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
61c9fa83a1f87fe7
Company
Wockhardt Limited
Type
Standard
Approval Details
Approval Id
61c9fa83a1f87fe7
Drug Approval Philippines Name
Nadiquin
Product Name
Nadiquin
Registration Number
DRP-8969
Brand Name
Nadiquin
Generic Name
Nadifloxacin
Dosage Form
Topical Cream
Dosage Strength
10 mg/g (1% w/w)
Manufacturer
Wockhardt Limited
Importer
Ambica International Corporation
Distributor
The Cathay Drug Co., Inc.
Company Detail Path
/organization/wockhardt-limited
Issuance Date
13 December 2022
Expiry Date
13 December 2027
Pharmacologic Category
Anti-acne
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
61c9fa83a1f87fe7
Type
Standard
Back to Philippines FDA Approvals